Skip to main content
SpringerLink
Log in

Treatment of Tuberculosis in Low-Income Countries

  • Chapter
Mycobacteria

Part of the book series: Chapman & Hall Medical Microbiology Series ((CHMMS))

  • 152 Accesses

Abstract

Lung diseases, including tuberculosis, account for an estimated 13% of all disability-adjusted life years lost as a result of disease; tuberculosis is second only to childhood pneumonia as a cause of death due to lung disease and the most frequent cause of death from a single infectious agent in the productive years of life (ages 15–49 years) (1,2). Nearly all deaths from tuberculosis occur in lowincome countries (3). In addition to these effects on mortality, a high proportion of all patients with tuberculosis in many industrialized countries (such as Canada, Switzerland, the United States, and the Scandinavian countries) were born in lowincome countries. Based on the above observations, for both humanitarian and strategic reasons, the control of tuberculosis in low-income countries should have a high priority for the world as a whole. Control of tuberculosis in industrialized, high-income countries cannot be accomplished without effective control programs in low-income countries. For this reason, it is essential that tuberculosis control be viewed in a global context.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. World Bank (1993) World Development Report 1993: Investing in health. Oxford: World Bank/Oxford University Press.

    Google Scholar 

  2. Sudre P, ten Dam G, Kochi A (1992) Tuberculosis: a global overview of the situation today. Bull WHO 70:149–159.

    PubMed  CAS  Google Scholar 

  3. Kochi A (1991) The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle 72:1–6.

    Article  PubMed  CAS  Google Scholar 

  4. Shaw JB, Wynn-Williams N (1954) Infectivity of pulmonary tuberculosis in relation to sputum status. Am Rev Tuberc 69:724–732.

    PubMed  CAS  Google Scholar 

  5. Loudon RG, Williamson J, Johnson JM (1958) An analysis of 3,485 tuberculosis contacts in the city of Edinburgh during 1954–1955. Am Rev Tuberc 77:623–643.

    PubMed  CAS  Google Scholar 

  6. Grzybowski S, Barnett GD, Styblo K (1975) Contacts of cases of active pulmonary tuberculosis. Bull Int Union Tuberc 50:90–106.

    PubMed  CAS  Google Scholar 

  7. Nsanzumuhire H, Lukwago EW, Edwards EA, Stott H, Fox W, Sutherland I (1977) A study of the use of community leaders in case-finding for pulmonary tuberculosis in the Machakos District of Kenya. Tubercle 58:117–128.

    Article  PubMed  CAS  Google Scholar 

  8. Grigg ERN (1958) The arcana of tuberculosis. Am Rev Tuberc 78:151–172.

    PubMed  CAS  Google Scholar 

  9. Cummins SL (1920) Tuberculosis in primitive tribes and its bearing on tuberculosis of civilized communities. Int J Publ Hlth 1:10–171.

    Google Scholar 

  10. Rutledge CJA, Crouch JB (1919) The ultimate results in 1694 cases of tuberculosis treated at the Modem Woodmen of America Sanatorium. Am Rev Tuberc 2:755–763.

    Google Scholar 

  11. Springett VH (1971) Ten-year results during the introduction of chemotherapy for tuberculosis. Tubercle 52:73–87.

    Article  PubMed  CAS  Google Scholar 

  12. Krebs W. Die Fälle von Lungentuberkulose in der Aangahischen Heilstätte Barmelwell aus der jahren 1912–27. Beitr Klin Tbk 74:345–379.

    Article  Google Scholar 

  13. National Tuberculosis Institute (1974) Tuberculosis in a rural population of South India: a five year epidemiological study. Bull WHO 51:473–488.

    Google Scholar 

  14. Rouillon A, Perdrizet S, Parrot R (1976) Transmission of tubercle bacilli: the effects of chemotherapy. Tubercle 57:275–299.

    Article  PubMed  CAS  Google Scholar 

  15. Enarson D, Rieder H, Arnadottir T (1991) Tuberculosis Guide for Low Income Countries, 3rd Ed. Paris: Les Editions de l’Aulne.

    Google Scholar 

  16. Ryan F (1992) Tuberculosis: The Greatest Story Never Told, pp. 148–170. Bromsgrove U.K.: Swift Publishers.

    Google Scholar 

  17. Collins JJ (1982) The contribution of medical measures to the decline of mortality from respiratory tuberculosis: an age-period-cohort model. Demography 19:409–427.

    Article  PubMed  CAS  Google Scholar 

  18. Crofton J (1960) Tuberculosis undefeated. Br Med J i:679.

    Google Scholar 

  19. Kakou M, and Kakihara H (1992) Analysis of chronic excretions of Mycobacterium tuberculosis in Aichi Perfecture. Kekkaku 67:29–44.

    Google Scholar 

  20. Canetti G (1955) The Tubercle Bacillus in the Pulmonary Lesions of Man. New York: Springer-Verlag.

    Google Scholar 

  21. Ryoken (1979) A study on prevalence of resistance to primary and secondary drugs among newly admitted pulmonary tuberculosis patients in 1977. Kekkaku 54:549–555.

    Google Scholar 

  22. Schulzer M, Enarson DA, Grzybowski S, Hong JP, Lim TP (1987) An analysis of pulmonary tuberculosis data from Taiwan and Korea. Int J Epidemiol 16:584–589.

    Article  PubMed  CAS  Google Scholar 

  23. Centers for Disease Control (1992) Transmission of multidrug-resistant Mycobacterium tuberculosis among immunocompromised persons in a correctional system-New York 1991. Morbid Mortal Wkly Rep 41:507–509.

    Google Scholar 

  24. World Health Organization (1974) WHO Expert Committee on Tuberculosis, Ninth Report. Geneva: World Health Organization.

    Google Scholar 

  25. Bannerji D, Anderson S (1963) A sociological study of awareness of symptoms among persons with pulmonary tuberculosis. Bull WHO 29:665–693.

    Google Scholar 

  26. Frimodt-Möller J (1962) Changes in tuberculosis prevalence in a south Indian rural community following a tuberculosis control programme over a seven years period (a preliminary report). Indian J Tuberc 9:187–191.

    Google Scholar 

  27. Hopewell PC, Sanchez-Hernandez M, Baron RB, Ganter B (1984) Operational evaluation of treatment for tuberculosis; results of a “standard” 12-month regimen in Peru. Am Rev Respir Dis 129:439–443.

    PubMed  CAS  Google Scholar 

  28. Enarson DA (1990) The tuberculosis control programme of international child care in Haiti. Unpublished report to the Canadian Lung Association.

    Google Scholar 

  29. Korean National Tuberculosis Association (1975) Report on the Third Tuberculosis Prevalence Survey in Korea. Seoul: Korean National Tuberculosis Association.

    Google Scholar 

  30. Aoki M (1984) Comments on the Results of the Sixth Tuberculosis Prevalence Survey in Taiwan Area. Tokyo: Research Institute of Tuberculosis Japan Anti-Tuberculosis Association.

    Google Scholar 

  31. Nationwide random survey for the epidemiology of pulmonary tuberculosis conducted in 1979. Chin J Respir Dis 5:67–71.

    Google Scholar 

  32. Datta M, Radhmani MP, Selvaraj R, Paramasivan CN, Gopalan BN, Sudeendra CR, Prabhakar R (1993) Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme. Tubercle Lung Dis 74:180–186.

    Article  CAS  Google Scholar 

  33. Grzybowski S (1993) Drugs are not enough; failure of short-course chemotherapy in a district in India. Tubercle Lung Dis 74:145–146.

    Article  CAS  Google Scholar 

  34. Iseman MD, Cohn DL and Sbarbaro JA (1993) Directly observed treatment of tuberculosis We can’t afford not to. New Engl J Med 328:576–578.

    Article  PubMed  CAS  Google Scholar 

  35. Enarson DA (1991) Principles of IUATLD Collaborative National Tuberculosis Programmes. Bull Int Union Tuberc Lung Dis 66:195–200.

    PubMed  CAS  Google Scholar 

  36. Murray CJ, DeJonghe E, Chum HJ, Nyangulu DS, Salomao A, Styblo K (1991) Costeffectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries. Lancet 338:1305–1308.

    Article  PubMed  CAS  Google Scholar 

  37. Kochi A (1991) The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle 72:1–6.

    Article  PubMed  CAS  Google Scholar 

  38. Manalo F, Tan F, Sbarbaro JA, Iseman MD (1990) Community-based short-course treatment of pulmonary tuberculosis in a developing nation. Am Redi Respir Dis 142:1301–1305.

    CAS  Google Scholar 

  39. Fox W (1990) Drug combinations and the bioavailability of rifampicin. (Discussion paper). Tubercle 71:241–245.

    Article  PubMed  CAS  Google Scholar 

  40. Acocella G (1989) Studies of bioavailability in man. Bull Int Union Tuberc Lung Dis 64:40–42.

    Google Scholar 

  41. Fox W, Mitchison DA (1975) Short-course chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis 111:325–353.

    PubMed  CAS  Google Scholar 

  42. International Union Against Tuberculosis and Lung Disease (1988) Antituberculosis regimens of chemotherapy. Recommendations from the Committee on Treatment of the IUATLD. Bull Int Union Tuberc Lung Dis 63:60–64.

    Google Scholar 

  43. World Health Organization Tuberculosis Programme (1993) Treatment of Tuberculosis: Guidelines for National Programmes. Geneva: World Health Organization.

    Google Scholar 

  44. Costello HD, Caras GJ, Snider DE (1980) Drug resistance among previously treated tuberculosis patients, a brief report. Am Rev Respir Dis 121:313–316.

    PubMed  CAS  Google Scholar 

  45. Boulahbal F, Khaled S, Tazir M (1989) The interest of follow-up of resistance of the tubercle bacillus in the evaluation of a programme. Bull Int Union Tuberc Lung Dis 64:23–25.

    PubMed  CAS  Google Scholar 

  46. Chonde TM (1989) The role of bacteriological services in the National Tuberculosis and Leprosy Programme in Tanzania. Bull Int Union Tuberc Lung Dis 64:37–39.

    PubMed  CAS  Google Scholar 

  47. Garcia FD, Mayorga H (1990) Relapse rate after short-course chemotherapy in smearpositive patients with pulmonary tuberculosis under routine conditions. Am Rev Respir Dis 141:A896.

    Google Scholar 

  48. Sbarbaro J (1981) The nature of man and physician (editorial). Am Rev Respir Dis 123:147.

    PubMed  CAS  Google Scholar 

  49. Rodier G, Gravier P, Sevre J-P, Binson G, Omar CS (1993) Multidrug-resistant tuberculosis in the Horn of Africa. J Infect Dis 168:523–524.

    Article  PubMed  CAS  Google Scholar 

  50. Kim SJ, Kim SC, Bai GH (1982) Drug resistance to Mycobacterium tuberculosis isolated from patients with pulmonary tuberculosis discovered in the fourth nationwide tuberculosis survey in Korea. Tubercle Lung Dis 29:1–10.

    Google Scholar 

  51. Jin BW, Kim SC, Mori T, Shimao T (1993) The impact of intensified supervisory activities on tuberculosis treatment. Tubercle Lung Dis 74:267–72.

    Article  CAS  Google Scholar 

  52. Stanford JL, Grange JM, Pozniak A (1991) Is Africa lost? Lancet 338:557–558.

    Article  PubMed  CAS  Google Scholar 

  53. Perriens JH, Colebunders RL, Karahunga C, Willame JC, Jengmons J, Kaboto M, Mukadi Y, Panwels P, Ryder RW, Prignol J et al. (1991) Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with “standard” chemotherapy in Kinshasa, Zaire. Am Rev Respir Dis 144:750–755.

    Article  PubMed  CAS  Google Scholar 

  54. Hawken M, Nunn PP, Gathua S, Brindle R, Godfrey-Faussett P, Githui W, Odhiambo J, Batchelor B, Gilks C, Morris J, McAdam K (1993) Increased recurrence of tuberculosis in HIV-1 infected patients in Kenya. Lancet 342:332–337.

    Article  PubMed  CAS  Google Scholar 

  55. Mohamed A, Lwechunguru S, Chum HJ, Styblo K, Broekmans JF (1990) Excess fatality, caused—to a great extent—by HIV infection, in smear-positive patients enrolled on short-course chemotherapy after sputum conversion. Am Rev Respir Dis 141:A267.

    Google Scholar 

  56. Enarson DA, Chum HJ, Gninafon M, Nyangulu DS, Salomao MA (1993) Tuberculosis and human immunodeficiency virus infection in Africa. In: Reichman LB, Hershfield ES, eds. Tuberculosis: A Comprehensive International Approach, pp. 395–412. New York: Marcel Dekker.

    Google Scholar 

  57. Small PM, Schechter GF, Goodman PC, Sande MA, Chaisson RE, Hopewell PC (1991) Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med 324:289–294.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Donald A. Enarson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philip C. Hopewell
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Chicago College of Medicine, University of Illinois, Chicago, Illinois, USA

    Pattisapu R. J. Gangadharam Ph.D. (Professor of Medicine, Microbiology, and Pathology, Director of Mycobacteriology Research) (Professor of Medicine, Microbiology, and Pathology, Director of Mycobacteriology Research)

  2. Public Health Laboratory Service, University Hospital of Wales, UK

    P. Anthony Jenkins Ph.D. (Director) (Director)

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Enarson, D.A., Hopewell, P.C. (1998). Treatment of Tuberculosis in Low-Income Countries. In: Gangadharam, P.R.J., Jenkins, P.A. (eds) Mycobacteria. Chapman & Hall Medical Microbiology Series. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-7511-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-7511-5_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4615-7513-9

  • Online ISBN: 978-1-4615-7511-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation